Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women

By Rymer J.   Robinson J.   Fogelman I.  

Climacteric, Vol. 5, Iss. 4, 2002-12 ,pp. : 390-398

Informa Healthcare

Access to resources Recommend Favorite

Climodien^® (estradiol valerate 2 mg plus dienogest 2 mg) is safe and effective in the treatment of postmenopausal complaints

By Gräser T.   Römer T.   Wiedey K. D.   Janaud A.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 332-342

Informa Healthcare

Access to resources Recommend Favorite

Delayed first injection of the once-a-month injectable contraceptive containing 25 mg of medroxyprogesterone acetate and 5 mg of E 2 -cypionate: effects on ovarian function

By Petta C.A.   Hays M.   Brache V.   Massai R.   Hua Y.   Alvarez-Sanchez F.   Croxatto H.   d'Arcangues C.   Cook L.A.   Bahamondes L.  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 744-748

Elsevier

Access to resources Recommend Favorite

A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism

By Muderris I.I.   Bayram F.   Guven M.  

Fertility and Sterility, Vol. 73, Iss. 5, 2000-05 ,pp. : 984-987

Elsevier

Access to resources Recommend Favorite

Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis

By Gennari Luigi   Merlotti Daniela   Nuti Ranuccio  

Expert Review of Obstretrics and Gynecology, Vol. 4, Iss. 6, 2009-11 ,pp. : 607-617

Informa Healthcare

Access to resources Recommend Favorite